Analysis of Disialyllacto-N-Tetraose (DSLNT) Content in Milk From Mothers of Preterm Infants

Abstract

Background

Human milk oligosaccharides (HMO) have been recognized for the protective effects they may elicit among high risk infants. One HMO, disialyllacto-N-tetraose (DSLNT), has been shown to reduce the risk for developing necrotizing enterocolitis in preterm infants.

Research aims

To measure DSLNT content in the human milk from mothers of preterm infants, and (1) assess variability; (2) establish correlations between maternal factors and/or an infant’s risk for developing necrotizing enterocolitis; and (3) determine the effect of pasteurization.

Methods

DSLNT was measured in 84 samples of preterm milk, in human donor milk, and in Holder and flash pasteurized samples. Preterm infant outcomes were assessed by medical record review.

Results

DSLNT content of mother’s own milk was highly variable and decreased significantly with increasing postnatal age. Four preterm infants (6.7%) developed necrotizing enterocolitis (Bell stage II or greater), 4 (6.7%) developed spontaneous intestinal perforation, and 1 developed both. DSLNT z-score was below the age-specific M within 8 (89%) of the 9 milk samples from mothers whose babies developed necrotizing enterocolitis (p = 0.039), but the DSLNT content did not differ between infants with necrotizing enterocolitis, spontaneous intestinal perforation, or neither condition (p > 0.1). DSLNT levels were significantly reduced in samples of donor milk compared to mothers’ own milk (p = 0.0051). Pasteurization did not significantly reduce DSLNT content.

Conclusions

DSLNT content of human milk is variable and may be lower in milk from mothers whose infants developed necrotizing enterocolitis. DSLNT content is unaffected by flash or Holder pasteurization.

Keywords

breastfeeding human milk neonatology prematurity very low birth weight

Get full access to this article

View all access options for this article.

References

Autran

C. A.

Kellman

B. P.

Kim

J. H.

Asztalos

Blood

A. B.

Spence

E. C. H.

Patel

A. L.

Hou

Lewis

N. E

Bode

(2018). Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants. Gut, 67(6), 1064–1070. https://doi.org/10.1136/gutjnl-2016-312819

Autran

C. A.

Schoterman

M. H.

Jantscher-Krenn

Kamerling

J. P.

Bode

(2016). Sialylated galacto-oligosaccharides and 2’-fucosyllactose reduce necrotising enterocolitis in neonatal rats. British Journal of Nutrition, 116(2), 294–299. https://doi.org/10.1017/S0007114516002038

Bell

M. J.

Ternberg

J. L.

Feigin

R. D.

Keating

J. P.

Marshall

Barton

Brotherton

(1978). Neonatal necrotizing enterocolitis. Therapeutic Decisions based upon clinical staging. Annals of Surgery, 187(1), 1–7. https://doi.org/10.1097/00000658-197801000-00001

Bode

(2015). The functional development of human milk oligosaccharide. Early Human Development 91(11):619–22. https://doi.org/10.1016/j.earlhumdev.2015.09.001

Eidelman

A. I.

(2012). Breastfeeding and the use of human milk: An analysis of the American Academy of Pediatrics 2012 Breastfeeding Policy Statement. Breastfeeding Medicine, 7(5), 323–324. https://doi.org/10.1089/bfm.2012.0067

Harris

P. A.

Taylor

Thielke

Payne

Gonzalez

Conde

J. G.

(2009). Research electronic data capture (REDCap): A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/10.1016/j.jbi.2008.08.010

Marx

Bridge

Wolf

A. K.

Rich

Kim

J. H.

Bode

(2014). Human milk oligosaccharide composition differs between donor milk and mother’s own milk in the NICU. Journal of Human Lactation, 30(1), 54–61. https://doi.org/10.1177/0890334413513923

McGuire

M. K.

Meehan

C. L.

McGuire

M. A.

Williams

J. E.

Foster

Sellen

D. W.

Kamau-Mbuthia

E. W.

Kamundia

E. W.

Mbugua

Moore

S. E.

Prentice

A. M.

Kvist

L. J.

Otoo

G. E.

Brooker

S. L.

Price

W. J.

Shafii

Placek

Lackey, . . .Bode

(2017a). What’s normal? Oligosaccharide concentrations and profiles in milk produced by healthy women vary geographically. American Journal of Clinical Nutrition, 105(5), 1086–1100. https://doi.org/10.3945/ajcn.116.139980

Monti

Cattaneo

T. M.

Orlandi

Curadi

M. C.

(2015). Capillary electrophoresis of sialylated oligosaccharides in milk from different species. Journal of Chromatography A, 1409, 288–291. https://doi.org/10.1016/j.chroma.2015.07.076

10.

O’Connor

D. L.

Gibbins

Kiss

Bando

Brennan-Donnan

Campbell, D.M., Vaz, S., Fusch, C., Asztalos, E., Church, P., Kelly, E., Ly, L., Daneman, A., Unger, S., and the DoMINO Feeding Group. (2016). Effect of supplemental donor human milk compared with preterm formula on neurodevelopment of very low-birth-weight infants at 18 months: A randomized clinical trial. The Journal of the American Medical Association, 316(18), 1897–1905. https://doi.org/10.1001/jama.2016.16144

11.

Quigley

Embleton

N. D.

McGuire

(2019). Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database of Systematic Reviews, 7, CD002971. https://doi.org/10.1002/14651858.CD002971.pub5

12.

Rasmussen

S. O.

Martin

Ostergaard

M. V.

Rudloff

Roggenbuck

Nguyen

D. N.

Sanguild, P.T., Bering

S. B.

(2017). Human milk oligosaccharide effects on intestinal function and inflammation after preterm birth in pigs. Journal of Nutritional Biochemistry, 40, 141–154. https://doi.org/10.1016/j.jnutbio.2016.10.011

13.

Van Niekerk

Autran

C. A.

Nel

D. G.

Kirsten

G. F.

Blaauw

Bode

. (2014). Human milk oligosaccharides differ between HIV-infected and HIV-uninfected mothers and are related to necrotizing enterocolitis incidence in their preterm very-low-birth-weight Infants. Journal of Nutrition, 144(8), 1227–1233. https://doi.org/10.3945/jn.113.187799